• Open Access
    • Comment cela fonctionne?
    • Ouvrir une session
    • Contact

    Voir le document

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Voir le document 
    • Accueil de LUCK
    • HE Bruxelles-Brabant
    • HE2B - HE
    • Santé
    • Voir le document
    • Accueil de LUCK
    • HE Bruxelles-Brabant
    • HE2B - HE
    • Santé
    • Voir le document
    Voir/Ouvrir
    De Bels - 2012 - Normobaric oxygen paradox Does it increase Hb.pdf (452.2Ko)
    Date
    2012-06-14
    Auteur
    De Bels, David
    THEUNISSEN, Sigrid
    Devriendt, Jacques
    GERMONPRÉ, Peter
    Lafère, Pierre
    Valsamis, Joseph
    SNOECK, Thyl
    Meeus, Philippe
    BALESTRA, Costantinoorcid-id
    Metadata
    Afficher la notice complète
    Partage ça

    The 'normobaric oxygen paradox': does it increase haemoglobin?

    Résumé
    Background: A novel approach to increasing erythropoietin (EPO) using oxygen (O2) (the 'normobaric oxygen paradox') has been reported in healthy volunteers. We investigated whether the EPO increase is sufficient to induce erythropoiesis by comparing two protocols of O2 administration. Methods: We compared the effect of daily versus alternate days 100% O2, breathed for 30 minutes, on haemoglobin concentrations during a 12-day period. Nine subjects underwent the two protocols six weeks apart. Results: We observed a significant increase in haemoglobin (as a percentage of baseline) in the alternate-days group compared to the daily group and to baseline after four days (105.5 ∓ 5.7 % vs. 99.6 ∓ 3.3 % difference from baseline; P < 0.01). At the end of the experimental period, haemoglobin values increased significantly compared to baseline in both groups. There was a significant percentage rise in reticulocyte count in the alternate-days group compared to the daily group (182 ∓ 94 % vs. 93 ∓ 34 %; P < 0.001). Conclusion: The normobaric oxygen paradox seems effective in increasing haemoglobin in non-anaemic, healthy volunteers, providing sufficient time is allowed between O2 applications. The exact time interval is not clearly defined by this study but should probably be at least or greater than two days. Further studies are needed to define more precisely clinical applications in the use of O2 as a pharmaceutical agent.

    Parcourir

    Tout LUCKCommunautés & CollectionsAuteurTitreDate de publicationSujetType de documentTitre de périodiqueThématiqueCette collectionAuteurTitreDate de publicationSujetType de documentTitre de périodiqueThématique

    Mon compte

    Ouvrir une sessionS'inscrire

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Plan du site

    • Open Access
    • Comment cela fonctionne?
    • Mon compte

    Contact

    • L’équipe de LUCK
    • Synhera
    • CIC